Logo image of JKS

JINKOSOLAR HOLDING CO-ADR (JKS) Stock Fundamental Analysis

NYSE:JKS - US47759T1007 - ADR

23.92 USD
+0.85 (+3.68%)
Last: 9/2/2025, 10:38:28 AM
Fundamental Rating

3

Taking everything into account, JKS scores 3 out of 10 in our fundamental rating. JKS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of JKS have multiple concerns. JKS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JKS had positive earnings in the past year.
Each year in the past 5 years JKS has been profitable.
Of the past 5 years JKS 4 years had a positive operating cash flow.
JKS Yearly Net Income VS EBIT VS OCF VS FCFJKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

The Return On Assets of JKS (-1.53%) is comparable to the rest of the industry.
JKS's Return On Equity of -10.18% is on the low side compared to the rest of the industry. JKS is outperformed by 66.96% of its industry peers.
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROIC N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
JKS Yearly ROA, ROE, ROICJKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

JKS's Profit Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 8.39%, JKS is doing worse than 89.29% of the companies in the same industry.
In the last couple of years the Gross Margin of JKS has declined.
JKS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
JKS Yearly Profit, Operating, Gross MarginsJKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. Health

2.1 Basic Checks

JKS does not have a ROIC to compare to the WACC, probably because it is not profitable.
JKS has less shares outstanding than it did 1 year ago.
JKS has more shares outstanding than it did 5 years ago.
JKS has a worse debt/assets ratio than last year.
JKS Yearly Shares OutstandingJKS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JKS Yearly Total Debt VS Total AssetsJKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

A Debt/Equity ratio of 1.80 is on the high side and indicates that JKS has dependencies on debt financing.
JKS has a Debt to Equity ratio of 1.80. This is amonst the worse of the industry: JKS underperforms 93.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC2.38%
JKS Yearly LT Debt VS Equity VS FCFJKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

2.3 Liquidity

A Current Ratio of 1.33 indicates that JKS should not have too much problems paying its short term obligations.
JKS has a worse Current ratio (1.33) than 85.71% of its industry peers.
A Quick Ratio of 1.07 indicates that JKS should not have too much problems paying its short term obligations.
JKS has a Quick ratio of 1.07. This is amonst the worse of the industry: JKS underperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.07
JKS Yearly Current Assets VS Current LiabilitesJKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

5

3. Growth

3.1 Past

The earnings per share for JKS have decreased strongly by -74.20% in the last year.
The Earnings Per Share has been decreasing by -2.87% on average over the past years.
The Revenue for JKS has decreased by -29.85% in the past year. This is quite bad
The Revenue has been growing by 25.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-74.2%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-334.93%
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%333.76%

3.2 Future

The Earnings Per Share is expected to grow by 41.24% on average over the next years. This is a very strong growth
Based on estimates for the next years, JKS will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y-339.75%
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
EPS Next 5YN/A
Revenue Next Year-24.38%
Revenue Next 2Y-0.39%
Revenue Next 3Y5.54%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JKS Yearly Revenue VS EstimatesJKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B 100B
JKS Yearly EPS VS EstimatesJKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.96, which indicates a very decent valuation of JKS.
98.21% of the companies in the same industry are more expensive than JKS, based on the Price/Earnings ratio.
JKS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.13.
JKS is valuated rather expensively with a Price/Forward Earnings ratio of 17.12.
Based on the Price/Forward Earnings ratio, JKS is valued cheaper than 80.36% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of JKS to the average of the S&P500 Index (22.76), we can say JKS is valued slightly cheaper.
Industry RankSector Rank
PE 8.96
Fwd PE 17.12
JKS Price Earnings VS Forward Price EarningsJKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

74.11% of the companies in the same industry are more expensive than JKS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.52
JKS Per share dataJKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

A more expensive valuation may be justified as JKS's earnings are expected to grow with 41.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.67%
EPS Next 3Y41.24%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.96%, JKS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.35, JKS pays a better dividend. On top of this JKS pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, JKS pays a better dividend.
Industry RankSector Rank
Dividend Yield 11.96%

5.2 History

JKS has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
JKS Yearly Dividends per shareJKS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1

5.3 Sustainability

DPN/A
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
JKS Yearly Income VS Free CF VS DividendJKS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

JINKOSOLAR HOLDING CO-ADR

NYSE:JKS (9/2/2025, 10:38:28 AM)

23.92

+0.85 (+3.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-28 2025-08-28/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners31.58%
Inst Owner Change-0.61%
Ins Owners4.9%
Ins Owner ChangeN/A
Market Cap1.24B
Analysts50.77
Price Target24.79 (3.64%)
Short Float %35.91%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield 11.96%
Yearly Dividend1.48
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-Date07-02 2025-07-02 (1.3)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-43.58%
Min Revenue beat(2)-87.85%
Max Revenue beat(2)0.7%
Revenue beat(4)1
Avg Revenue beat(4)-65.07%
Min Revenue beat(4)-88.26%
Max Revenue beat(4)0.7%
Revenue beat(8)1
Avg Revenue beat(8)-75.3%
Revenue beat(12)4
Avg Revenue beat(12)-47.34%
Revenue beat(16)5
Avg Revenue beat(16)-36.87%
PT rev (1m)0%
PT rev (3m)1.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.03%
EPS NY rev (1m)-16.68%
EPS NY rev (3m)-5.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.74%
Valuation
Industry RankSector Rank
PE 8.96
Fwd PE 17.12
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB 0.55
EV/EBITDA 16.52
EPS(TTM)2.67
EY11.16%
EPS(NY)1.4
Fwd EY5.84%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS225.38
BVpS49.94
TBVpS43.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.39%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Debt/EBITDA 10.8
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.07
Altman-Z N/A
F-ScoreN/A
WACC2.38%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.2%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-334.93%
EPS Next Y-339.75%
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%333.76%
Revenue Next Year-24.38%
Revenue Next 2Y-0.39%
Revenue Next 3Y5.54%
Revenue Next 5YN/A
EBIT growth 1Y-189.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year204.26%
EBIT Next 3Y124.49%
EBIT Next 5YN/A
FCF growth 1Y-45.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.87%
OCF growth 3Y239.49%
OCF growth 5Y64.22%